A novel sulfur containing heteroaryl-pyrazole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB
1
receptor inverse agonist or antagonist, which is useful for preventing or treating obesity and obesity-related metabolic disorders. The prevention also provide a method for preparing same, a pharmaceutical composition containing same, and a method for preventing or treating obesity and obesity-related metabolic disorders.
一种含
硫杂环
吡唑烷化合物,
化学式为(I),或其药学上可接受的盐,作为一种
大麻素CB1受体的反向激动剂或拮抗剂具有有效性,可用于预防或治疗肥胖和与肥胖相关的代谢性疾病。该预防方法还提供了一种制备相同的方法,含有相同的药物组合物,以及预防或治疗肥胖和与肥胖相关的代谢性疾病的方法。